SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-041858
Filing Date
2022-07-27
Accepted
2022-07-27 06:08:30
Documents
15
Period of Report
2022-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea163386-8k_somalogic.htm   iXBRL 8-K 45461
2 AGREEMENT AND PLAN OF MERGER, DATED AS OF JULY 25, 2022, BY AND AMONG SOMALOGIC, ea163386ex2-1_somalogic.htm EX-2.1 829698
3 PRESS RELEASE, DATED JULY 26, 2022 ea163386ex99-1_somalogic.htm EX-99.1 13189
  Complete submission text file 0001213900-22-041858.txt   1272353

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE slgc-20220725.xsd EX-101.SCH 3806
5 XBRL DEFINITION FILE slgc-20220725_def.xml EX-101.DEF 26767
6 XBRL LABEL FILE slgc-20220725_lab.xml EX-101.LAB 37000
7 XBRL PRESENTATION FILE slgc-20220725_pre.xml EX-101.PRE 25391
9 EXTRACTED XBRL INSTANCE DOCUMENT ea163386-8k_somalogic_htm.xml XML 5750
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 221108736
SIC: 8731 Services-Commercial Physical & Biological Research